Alberta Auditor-General rushing health care probe after government denies term extension | Unpublished
Hello!
Source Feed: The Globe and Mail
Author: Carrie Tait
Publication Date: November 3, 2025 - 21:17

Stay informed

Alberta Auditor-General rushing health care probe after government denies term extension

November 3, 2025

Alberta’s Auditor-General is racing to complete his investigation into procurement practices in the province’s health care system within the next six months, after the government rejected his proposal to extend his contract until the probe is finished.

Doug Wylie’s eight-year term as the province’s Auditor-General expires at the end of April, 2026. The governing United Conservative Party on Monday confirmed it would conduct a search to fill the position, noting Mr. Wylie is welcome to apply for the job.



Unpublished Newswire

 
Alberta Premier Danielle Smith pointed to her advisers when asked to explain how an Edmonton businessman whose contracts with the province’s health agency are now under scrutiny ended up in a hotel suite with her top lieutenants on the night of the 2023 provincial election. A Globe and Mail investigation published over the weekend examined the links between medical supply company executive Sam Mraiche and Ms. Smith’s government. The Globe found Mr. Mraiche, whose company MHCare was awarded more than $600-million in contracts with Alberta Health Services, had more extensive connections to...
December 1, 2025 - 22:01 | Matthew Scace, Emma Graney | The Globe and Mail
For now, Cole says he walks the perimeter of his home every night, checking for any unwanted visitors and hoping nothing like this happens again.
December 1, 2025 - 21:55 | Victoria Femia | Global News - Canada
More cases of prostate cancer were diagnosed at Stage 4 in recent years compared with about a decade earlier, a development that experts behind a new study suggest could be linked with official recommendations discouraging the use of a hotly debated screening test.The prostate-specific antigen test is a simple blood test that can serve as an early warning signal of cancer in men with no symptoms. But the test also has risks: It can lead to overdiagnosis and overtreatment of slow-growing prostate tumours that might never have caused harm had they remained undiscovered. For that reason, a...
December 1, 2025 - 20:45 | Kelly Grant | The Globe and Mail